As STING expression was reduced in SCLC subtype as interferon response, we performed a correlation analysis of STING expression and “Response to Interferon Beta” gene set enrichment for each cancer type showing a positive but slight correlation between STING and “Response to Interferon Beta” GO process in LUSC and neuroendocrine cancer types (SCLC and LCNEC) but not in LUAD (Fig. 6e). The gene discussed is STING1; the disease is large cell neuroendocrine carcinoma.